| Selective targeting of IL-2 to NKG2D bearing cells for improved immunotherapy R Ghasemi, E Lazear, X Wang, S Arefanian, A Zheleznyak, BM Carreno, ... Nature Communications 7 (1), 12878, 2016 | 68 | 2016 |
| Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated … M Momeny, M Zakidizaji, R Ghasemi, AR Dehpour, M Rahimi_Balaei, ... Medical Oncology 27, 833-842, 2010 | 55 | 2010 |
| Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma L Lupini, F Pepe, M Ferracin, C Braconi, E Callegari, S Pagotto, R Spizzo, ... Oncotarget 7 (21), 31361, 2016 | 51 | 2016 |
| Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer R Lattanzio, R Ghasemi, F Brancati, RL Sorda, N Tinari, L Perracchio, ... Oncogenesis 3 (9), e118-e118, 2014 | 50 | 2014 |
| Silibinin inhibits invasive properties of human glioblastoma U87MG cells through suppression of cathepsin B and nuclear factor kappa B-mediated induction of matrix … M Momeny, M Malehmir, M Zakidizaji, R Ghasemi, H Ghadimi, ... Anti-cancer drugs 21 (3), 252-260, 2010 | 48 | 2010 |
| Multitargeting and antimetastatic potentials of silibinin in human HepG-2 and PLC/PRF/5 hepatoma cells R Ghasemi, SH Ghaffari, M Momeny, S Pirouzpanah, M Yousefi, ... Nutrition and cancer 65 (4), 590-599, 2013 | 41 | 2013 |
| EV20, a novel anti-ErbB-3 humanized antibody, promotes ErbB-3 down-regulation and inhibits tumor growth in vivo G Sala, IG Rapposelli, R Ghasemi, E Piccolo, S Traini, E Capone, C Rossi, ... Translational Oncology 6 (6), 676-IN9, 2013 | 33 | 2013 |
| Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells M Momeny, G Zarrinrad, F Moghaddaskho, A Poursheikhani, ... Scientific Reports 7 (1), 4204, 2017 | 31 | 2017 |
| Tumor-derived microvesicles: the metastasomes R Ghasemi, A Grassadonia, N Tinari, E Piccolo, C Natoli, F Tomao, ... Medical hypotheses 80 (1), 75-82, 2013 | 28 | 2013 |
| Contribution of CTCF binding to transcriptional activity at the HOXA locus in NPM1-mutant AML cells R Ghasemi, H Struthers, ER Wilson, DH Spencer Leukemia 35 (2), 404-416, 2021 | 22 | 2021 |
| Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer R Ghasemi, IG Rapposelli, E Capone, C Rossi, R Lattanzio, M Piantelli, ... Oncogenesis 3 (8), e117-e117, 2014 | 21 | 2014 |
| Effects of silibinin on growth and invasive properties of human ovarian carcinoma cells through suppression of heregulin/HER3 pathway M Momeny, R Ghasemi, G Valenti, M Miranda, A Zekri, G Zarrinrad, ... Tumor Biology 37, 3913-3923, 2016 | 18 | 2016 |
| Targeting of IL-2 to cytotoxic lymphocytes as an improved method of cytokine-driven immunotherapy E Lazear, R Ghasemi, SM Hein, J Westwick, D Watkins, DH Fremont, ... Oncoimmunology 6 (2), e1265721, 2017 | 14 | 2017 |
| Deficiency of the adaptor protein SLy1 results in a natural killer cell ribosomopathy affecting tumor clearance S Arefanian, D Schäll, S Chang, R Ghasemi, R Higashikubo, ... Oncoimmunology 5 (12), e1238543, 2016 | 12 | 2016 |
| Persistent molecular disease in adult patients with AML evaluated with whole-exome and targeted error-corrected DNA sequencing MJ Slade, R Ghasemi, M O'Laughlin, T Burton, RS Fulton, HJ Abel, ... JCO Precision Oncology 7, e2200559, 2023 | 2 | 2023 |
| Towards solving the genetic diagnosis odyssey in Iranian patients with congenital anomalies P Vaseghi, L Habibi, JA Neidich, Y Cao, N Fattahi, R Rashidi-Nezhad, ... European Journal of Human Genetics, 1-12, 2024 | 1 | 2024 |
| P697: Prenatal diagnosis and postnatal clinical course of a fetus with low-level mosaic trisomy 17q R Ghasemi, C Trammel, N Jensen, A Stanley, S Smith, M Schroeder, ... Genetics in Medicine Open 2, 2024 | | 2024 |
| P468: A comparative analysis of TEK variants in patients with vascular anomalies R Ghasemi, M Corliss, K Krysiak, B Parikh, A Dickson, K Bowling, ... Genetics in Medicine Open 1 (1), 2023 | | 2023 |
| Homozygous Loss of a Critical CTCF Recognition Sequence in the HOXA gene Cluster Eliminates CTCF Binding but Does Not Appreciably Reduce HOXA9 expression in NPM1 Mutated AML Cells R Ghasemi, SB Heidi, DH Spencer Blood 132, 2613, 2018 | | 2018 |
| Dual targeting of ErbB-2 and ErbB-3: A new potential strategy for the treatment of pancreatic cancer G Sala, R Ghasemi, E Capone, IG Rapposelli, S Traini, C Rossi, PG Natali, ... Cancer Research 74 (19_Supplement), 5437-5437, 2014 | | 2014 |
Majid MomenyTexas Medical CenterVerified email at uth.tmc.edu
